LEO Reports 16-week Results of Tralokinumab in P-III ECZTRA 6 Trial for the Treatment of Moderate-to-Severe Atopic Dermatitis Published: 22 Oct, 2021 | Tags: LEO, Tralokinumab, P-III, ECZTRA 6 Trial, […]readmore
Tags : Assembly Biosciences
Shots: The companies collaborated to evaluate the safety, PK & antiviral activity of ATI-2173, vebicorvir & TDF in an ongoing P-IIa ANTT201 trial in 10 treatment naïve or off-treatment HBeAg […]readmore
The biopharma industry saw numerous deal terminations in 2020. Clinical and regulatory results, change in control limitations, and strategic reprioritizations were among the most common reasons for deal termination. Sanofi […]readmore